Title:
併用療法
Document Type and Number:
Japanese Patent JP5167144
Kind Code:
B2
Abstract:
The present invention relates to a method for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation, particularly a method for the treatment of a cancer, particularly a cancer involving a solid tumour, which comprises the administration of ZD6474 in combination with pemetrexed; to a pharmaceutical composition comprising ZD6474 and pemetrexed; to a combination product comprising ZD6474 and pemetrexed for use in a method of treatment of a human or animal body by therapy; to a kit comprising ZD6474 and pemetrexed; to the use of ZD6474 and pemetrexed in the manufacture of a medicament for use in the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human which is optionally being treated with ionising radiation.
More Like This:
Inventors:
Wedge, Stephen Robert
Liang, Anderson Joseph
Liang, Anderson Joseph
Application Number:
JP2008546586A
Publication Date:
March 21, 2013
Filing Date:
December 19, 2006
Export Citation:
Assignee:
AstraZeneca Activrag
International Classes:
A61K31/519; A61K31/517; A61P11/00; A61P35/00
Foreign References:
| WO2004071397A1 |
Other References:
INT.J.RADIATION ONCOLOGY BIOL.PHYS.,2004年,VOL.60, NO.4,P.1220-1232
Attorney, Agent or Firm:
Shinjiro Ono
Kazuo Shamoto
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita
Kazuo Shamoto
Yasushi Kobayashi
Akio Chiba
Hiroyuki Tomita